Roman Šink

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Košak, Boris Brus, Damijan Knez et al. · Scientific Reports · 2016 · 163 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Urban Košak, Boris Brus, Damijan Knez et al. · Journal of Medicinal Chemistry · 2017 · 156 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Novel 5-Benzylidenerhodanine and 5-Benzylidenethiazolidine-2,4-dione Inhibitors of MurD Ligase

Nace Zidar, Tihomir Tomašič, Roman Šink et al. · Journal of Medicinal Chemistry · 2010 · 99 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +15

Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis

Roman Šink, Izidor Sosič, Matej Živec et al. · Journal of Medicinal Chemistry · 2014 · 78 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents

Damijan Knez, Boris Brus, Nicolas Coquelle et al. · Bioorganic & Medicinal Chemistry · 2015 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16